Publications by authors named "N I Rybakova"

Background: Despite the low transmission risk of Monkeypox (mpox) in Belarus, this study is vital as it contributes to our understanding of vaccine hesitancy among healthcare professionals (HCPs). It aims to assess vaccination perceptions and evaluate the willingness to pay for the vaccine among Belarusian HCPs, thereby enhancing pandemic preparedness.

Methods: in October 2022, a cross-sectional survey-based study was conducted among Belarusian HCPs using a self-administered questionnaire (SAQ).

View Article and Find Full Text PDF

The results of comprehensive X-ray findings in 300 patients with different clinical and X-ray forms of respiratory sarcoidosis who had been registered to be followed up at the Consulting Outpatient Department, Central Research Institute of Tuberculosis Russian Academy of Medical Sciences, were analyzed. The follow-up lasted 3 to 20 years. X-ray study heads the list of the most informative techniques for assessing the activity of sarcoidosis.

View Article and Find Full Text PDF

Based on epizootological and epidemiological investigations in the Vologda province since 1958 till 2000, the combined territorial and temporal manifestations of natural foci of diseases was revealed. A natural focus occupies a complex of biotopes, and in different time the focus is activated in different areas, such as a river plain, marsh, meadow-field, and forest. Most commonly an activation of the natural focus appears in a border zone of three biotopes, namely, a forest, meadow-field, and river plain.

View Article and Find Full Text PDF

Treatments were comparatively analyzed in two groups comprising 106 patients with respiratory sarcoidosis. One group of patients (n = 52) was treated with conventional therapy (corticosteroid hormones as tablets or aerosols, physiotherapy, SWF, plaquenil, antioxidants, the other (n = 54) received combined therapy (plasmapheresis, reduced hormone dosage, antioxidants. With both treatments, the early results of treatment were equally positive in 60-63% of patients, mainly in new cases of sarcoidosis.

View Article and Find Full Text PDF